Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
Apply
Tagraxofusp & Azacitidine
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step